§ Funding Round
Series A funding round for 858 Therapeutics raising $60M in September 2021
Series A funding round for 858 Therapeutics raising $60M in September 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Angel | ali behbahani | |
New Enterprise Associates | — | — |
Versant VenturesLEAD | Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$110M
Top Valuation
-
858 Therapeutics raised $60M in a Series A round.
The round was announced on 09/01/21.
The round was led by Versant Ventures.
